scispace - formally typeset
Z

Zhong Chen

Researcher at King's College London

Publications -  58
Citations -  1811

Zhong Chen is an academic researcher from King's College London. The author has contributed to research in topics: Cardiac resynchronization therapy & Heart failure. The author has an hindex of 19, co-authored 52 publications receiving 1554 citations. Previous affiliations of Zhong Chen include University of Cambridge & Center for Excellence in Education.

Papers
More filters
Journal ArticleDOI

Left ventricular epicardial electrograms show divergent changes in action potential duration in responders and nonresponders to cardiac resynchronization therapy.

TL;DR: In patients with heart failure, LV epicardial APD (activation recovery interval) altered during CRT, which may provide an explanation for the persistent high incidence of arrhythmias in some patients with CRT and the additional mortality benefit observed in responders of CRT.
Journal ArticleDOI

Glycosylation of glycopeptides: a comparison of chemoenzymatic and chemical methods

TL;DR: The efficiency of chemical and enzymatic methods for glycosylation of glycopeptides related to vancomycin are compared and the parameters that should be considered in designing synthetic approaches to Glycosylated natural product derivatives are described.
Journal ArticleDOI

Current concepts relating coronary flow, myocardial perfusion and metabolism in left bundle branch block and cardiac resynchronisation therapy.

TL;DR: There remains a need for further research to clarify the interaction of coronary flow with perfusion and metabolism in patients who undergo CRT, as CRT appears to improve homogeneity in myocardial perfusion.
Journal ArticleDOI

Lower incidence of inappropriate shock therapy in patients with combined cardiac resynchronisation therapy defibrillators (CRT-D) compared with patients with non-CRT defibrillators (ICDs).

TL;DR: An increasing number of patients with advanced heart failure receive combined ICD and cardiac resynchronisation therapy devices (CRT‐D) and a significant number experience inappropriate shock therapy from implantable cardioverter‐defibrillators.